DNA ploidy measurement and human papillomavirus in abnormal cervical cytology.
Ane Francyne CostaAdriane PogereAna Paula Beltrame Farina PasinatoEdson Jose Monteiro BelloAlexandre Sherlley Casimiro OnofreFabiana Botelho de Miranda OnofrePublished in: Cytopathology : official journal of the British Society for Clinical Cytology (2020)
DNA-ICM or HR-HPV positivity identified all cases of ≥CIN2 in women undergoing follow-up procedure after a previous abnormal cervical cytology. Routine cervical cancer screening could be improved by the incorporation of DNA-ICM as a complementary method to primary screening to identify which women need closer follow-up.